Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

3683.31 (Glytoucan)

Id:2c94d259-a854-55d3-b453-4f50965124f1

Glytoucan:G96445EY

Results found

Linked to

	Label	Description
	3683.31 has canonical residue n-glycan a-d-neupnac 73 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G47456CG-GLYCOSEQ00152101 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3683.31 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000023 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G08005PG-GLYCOSEQ00170510 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3683.31 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000017 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3683.31 has canonical residue n-glycan a-d-manp 4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G32761XQ-GLYCOSEQ00053331 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G59470RP-GLYCOSEQ00038275 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G46103YX-GLYCOSEQ00121907 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G47456CG-GLYCOSEQ00152103 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3683.31 has canonical residue n-glycan a-d-neupnac 73

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G47456CG-GLYCOSEQ00152101 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3683.31 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000023 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G08005PG-GLYCOSEQ00170510 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3683.31 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000017 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3683.31 has canonical residue n-glycan a-d-manp 4

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G32761XQ-GLYCOSEQ00053331 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G59470RP-GLYCOSEQ00038275 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G46103YX-GLYCOSEQ00121907 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3683.31 has glycosequence GLYGEN.GLYCOSEQUENCE:G47456CG-GLYCOSEQ00152103 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.